|
|
 |
|
 |
 |
 |
 |
|
|
|
|
| Randy J. Irwin, MD, FACS |
 |
Practice Location:
8433 Harcourt Road, Suite 100
Indianapolis, Indiana 46260
PH: 317-583-7600
FAX: 317-583-7601
info@corvascmds.com |
Specialty:
Vascular Surgery
Medical Interests:
Gene Therapy/Angiogenesis
Board Certification:
Board certified in Vascular Surgery
Board certified in General Surgery
Education:
University of New Mexico, Albuquerque, New Mexico
Bachelor of Science in Biomedical Engineering, 1985 - 1989
The Ohio State University, Columbus, Ohio
Medical Degree, 1989 - 1993
University of Oklahoma, Oklahoma City, Oklahoma
General Surgery Resident, 1993- 1996
University of Oklahoma, Oklahoma City, Oklahoma
Research Fellowship, 1996 - 1997
University of Oklahoma, Oklahoma City, Oklahoma
General Surgery Resident, 1997- 1999
The Ohio State University, Columbus, Ohio
Vascular Surgery Fellowship, 1999 - 2000
Hospital Privileges:
St.Vincent Hospital, Indianapolis, IN
Clarian/Methodist Hospital, Indianapolis, IN
Orthopaedic Hospital of Indiana, Indianapolis, IN
Professional Societies:
American College of Surgeons
Indiana State Medical Association
Marion County Medical Society
Clinical Research:
1. 0.5 A Phase 3b, Open-Label, Single-Group
Immunogenicity and Safety Study of Topical Recombinant
Thrombin in Surgical Hemostasis. Principal Investigator
2. 0.75 A Phase II, Multicenter, Multi-national, Randomized,
Double-blind, Placebo controlled, Parallel, study of the
effects of GB-BH-4 on Symptomatic Peripheral Arterial
Disease. Subinvestigator
3. AGI-0205, A Phase II Double-Blind, Randomized,
Placebo-controlled Study to study and Assess the Safety and
Efficacy of AMG0001 to Improve Perfusion in Critical Limb Ishemia in Subjects who have Peripheral Ischemic Ulcers by
Anges Inc. SubInvestigator.
4. A Phase II, Randomized, Double-Blind, Placebo-controlled,
Parallel group, Multicenter, Dose-Selection Study of
Ad2/Hypoxia Inducible Factor (HIF)-1alpha/VP16 in Patients
with Intermittent Claudication by Genzyme Corporation.
Principal Investigaor.
5. Double-Blind, Randomized, Placebo-controlled, parallel
group and dose-finding, multicenter efficacy and Safety
Study with Intramuscular dose Regimens of NV1FGF in subjects
with intermittent claudication (Talisman 211 Study) by
Centelion. SubInvestigator.
6. ZenithÆ TX2™ Thoracic TAA Endovascular Graft Clinical
Study by Cook Scientific. Subinvestigator.
7. A Phase II Randomized, Double-blind, Placebo-controlled,
Parallel group, Efficacy and Safety Study of different doses
and schedules of administration of NV1FGF in patients with
severe peripheral artery occlusive disease by Aventis.
Principal Investigator.
8. A Phase II Multicenter, Double-blind, Placebo-controlled,
trial of VLTS-589 in subjects with intermittent claudication
secondary to peripheral arterial disease by Valentis, Inc.
Principal Investigator.
9. A Phase II double-blind, Randomized, Placebo-0controled
study to assess the safety and efficacy of AMG0001 to
improve perfusion in critical leg ischemia by Anges, Inc.
Principal Investigator.
10. Evaluation of SURGISIS Peripheral Vascular Patch
Following Use in Carotid Endarterectomy by Cook Biotech Inc.
Principal Investigator.
11. A Double-blind, Efficacy and Safety Study of the Oral
Direct Thrombin Inhibitor, H376/95 versus Standard Therapy
in Patients with Acute, Symptomatic Deep Venous Thrombosis
with and without Pulmonary Embolism (THRIVE V) by
AstraZeneca. Principal Investigator.
12. Recombinant Urokinase (ABT-120, urokinase alpha) in the
Treatment of Occluded Central Venous Catheters, Safety and
Efficacy Trial by Abbott Laboratories. Principal
Investigator.
Publications:
McCready RA, Hode J, Irwin RJ: Pseudoaneurysm
formation in a subset of patients with small intestinal
submucosa biologic patches after carotid endarterectomy.
Journal of Vascular Surgery. 2005; 46:783-8.
Irwin RJ and Jacocks MA: High Internal Carotid Artery
Aneurysm Related to Pregnancy: A Case Report. Annals of
Vascular Surgery. 2000; 14:405-409.
Irwin RJ, Lerner MR, Bealer JF: Shock after Primary
Blast Injury is caused by a Vagally Mediated Reflex. Journal
of Trauma. 1999; 47:105-110.
Irwin RJ, Lerner MR, Lightfoot SA: Global Primary
Blast Injury: A Rat Model. J Oklahoma State Med Assoc. 1998;
91:387-392.
Irwin RJ, Lerner MR, Bealer JF. The Cardiopulmonary
Physiology of Primary Blast Injury. Journal of Trauma. 1997;
43:650-655.
Irwin RJ, Lerner MR, Lightfoot SA.: Global Primary
Blast Injury: A Rat Model. SHOCK. Supplement 2 1997;
V7S2:15-16.
Chen BT, Irwin RJ, Cheng YS. Aerodynamic Behavior of
Fiber- and Disc-like Particles in a Millikan Cell. Journal
of Aerosol Science. 1993; 24:181-195.
|
|
|
|
|
